Transforming growth factor-ß1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
Cytotherapy
; 21(5): 535-545, 2019 05.
Article
en En
| MEDLINE
| ID: mdl-30685215
ABSTRACT
BACKGROUND:
Regulatory T cells (Tregs) suppress excessive immune responses and play a crucial protective role in acute kidney injury (AKI). The aim of this study was to examine the therapeutic potential of transforming growth factor (TGF)-ß1-overexpressing mesenchymal stromal cells (MSCs) in inducing local generation of Tregs in the kidney after ischemia/reperfusion (I/R) injury.METHODS:
MSCs were transduced with a lentiviral vector expressing the TGF-ß1 gene; TGF-ß1-overexpressing MSCs (designated TGF-ß1/MSCs) were then transfused into the I/R-injured kidney via the renal artery.RESULTS:
MSCs genetically modified with TGF-ß1 achieved overexpression of TGF-ß1. Compared with green fluorescent protein (GFP)/MSCs, TGF-ß1/MSCs markedly improved renal function after I/R injury and reduced epithelial apoptosis and subsequent inflammation. The enhanced immunosuppressive and therapeutic abilities of TGF-ß1/MSCs were associated with increased generation of induced Tregs and improved intrarenal migration of the injected cells. Futhermore, the mechanism of TGF-ß1/MSCs in attenuating renal I/R injury was not through a direct canonical TGF-ß1/Smad pathway.CONCLUSION:
TGF-ß1/MSCs can induce a local immunosuppressive effect in the I/R-injured kidney. The immunomodulatory activity of TGF-ß1-modified MSCs appears to be a gateway to new therapeutic approaches to prevent renal I/R injury.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Daño por Reperfusión
/
Trasplante de Células Madre Mesenquimatosas
/
Factor de Crecimiento Transformador beta1
/
Células Madre Mesenquimatosas
/
Enfermedades Renales
Límite:
Animals
Idioma:
En
Revista:
Cytotherapy
Asunto de la revista:
TERAPEUTICA
Año:
2019
Tipo del documento:
Article
País de afiliación:
China